Reduction in myocardial infarct size by basic fibroblast growth factor after temporary coronary occlusion in a canine model

Circulation

Volumn 94, Issue 8, 1996, Pages 1927-1933

  Korrigan, Mark C G ^a   MacIsaac, Andrew I ^a   Nicolini, Francesca A ^a   Vince, D Geoffrey ^b   Lee, Philmo ^a   Ellis, Stephen G ^a   Topol, Eric J ^a,b  

^a Department of Cardiology   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

growth substances; myocardial infarction; vasodilation; vessels

Indexed keywords

CYCLINE; GLYCERYL TRINITRATE; HIRULOG; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR; THROMBIN INHIBITOR; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DOG; EXPERIMENTAL MODEL; FEMALE; HEART INFARCTION; HEART INFARCTION SIZE; INTRACORONARY INFUSION; INTRAVENOUS DRUG ADMINISTRATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME; VASODILATATION;

EID: 0029841530     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.cir.94.8.1927     Document Type: Article

References (39)

1. Vandeplassche G, Hermans C, Von Haecke J, Wouters L, Borgers M, Flameng W. Evaluation of factors influencing myocardial infarct size in unconscious dogs. Cardiovasc Res. 1991;25:844-854.
2. Reimer KA, Lowe JE, Rasmussen MM, Jennings RB. The wave front phenomenon of ischemic cell death, I: myocardial infarction size vs duration of coronary occlusion in dogs. Circulation. 1977;56:786-794.
3. Lazarous DF, Scheinowitz M, Shou M, Hodge E, Rajanayagam S, Hunsberger S, Robinson WG, Stiber JA, Correa R, Epstein SE, Unger EF. Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. Circulation. 1995;91:145-153.
4. Unger EF, Banai S, Shou M, Lazarous DF, Jaklitsch MT, Scheinowitz M, Correa R, Klingbeil C, Epstein SE. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model. Am J Physiol. 1994;266:H1588-H1595.
5. Yanagisawa-Miwa A, Uchida Y, Nakamura F, Tomaru T, Kido H, Kamijo T, Sugimoto T, Kaji K, Utsuyama M, Kurashima C, Ito H. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science. 1992;257:1401-1403.
6. Sabia PJ, Powers ER, Ragosta M, Sarembock IJ, Burwell LR, Kaul S. An association between collateral blood flow and myocardial viability in patients with recent myocardial infarction. N Engl J Med. 1992;327:1825-1831.
7. Goldberg HL, Goldstein J, Borer JS, Moses JW, Collins MB. Functional importance of coronary collateral vessels. Am J Cardiol. 1984;53:694-699.
8. Vlodavsky I, Fridman R, Sullivan R, Sasse J, Klagsbrun M. Aortic endothelial cells synthesize basic fibroblast growth factor which remains cell associated and platelet-derived growth factor-like protein which is secreted. J Cell Physiol. 1987;131:402-408.
9. Speir E, Sasse J, Shrivastav S, Casscells W. Culture-induced increase in acidic and basic fibroblast growth factor activities arid their association with the nuclei of vascular endothelial and smooth muscle cells. J Cell Physiol. 1991;147:362-373.
10. Baird A, Mormede P, Bohlen P. Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggests its identity with macrophage-derived growth factor. Biochem Biophys Res Commun. 1985;126:358-364.
11. Esch F, Baird A, Ling N, Ueno N, Hill F, Denoroy L, Klepper R, Gospodarowicz D, Bohlen P, Guillemin R. Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF. Proc Natl Acad Sci USA. 1985;82:6507-6511.
12. Quinkler W, Maasberg M, Bernotat-Danielowski S, Luthe N, Sharma HS, Schaper W. Isolation of heparin-binding growth factors from bovine, porcine and canine hearts. Eur J Biochem. 1989;181:67-73.
13. Casscells W, Speir E, Sasse J, Klagsbrun M, Allen P, Lee M, Calvo B, Chiba M, Haggroth L, Folkman J, Epstein SE. Isolation, characterization, and localization of heparin-binding growth factors in the heart. J Clin Invest. 1990;85:433-441.
14. Montesano R. Regulation of angiogenesis in vitro. Eur J Clin Invest. 1992;22:504-515.
15. Tamm I, Kikuchi T, Zychlinsky A. Acidic and basic fibroblast growth factors are survival factors with distinctive activity in quiescent BALB/c 3T3 murine fibroblasts. Proc Natl Acad Sci U S A. 1991;88:3372-3376.
16. Speir E, Tanner V, Gonzalez AM, Farris J, Baird A, Casscells W. Acidic and basic fibroblast growth factors in adult rat heart myocytes: localization, regulation in culture, and effect on DNA synthesis. Circ Res. 1992;71:251-259.
17. Engelmann GL, Dionne CA, Jaye MC. Acidic fibroblast growth factor and heart development: role in myocyte proliferation and capillary angiogenesis. Circ Res. 1993;72:7-19.
18. Unger EF, Shou M, Sheffield CD, Hodge E, Jaye M, Epstein SE. Extracardiac to coronary anastomoses support regional left ventricular function in dogs. Am J Physiol. 1993;264:H1567-H1574.
19. Cuevas P, Carceller F, Ortega S, Zazo M, Nieto I, Gimenez-Gallego G. Hypotensive activity of fibroblast growth factor. Science. 1991;254:1208-1210.
20. Lefkovits J, Topol EJ. Direct thrombin inhibitors in cardiovascular medicine. Circulation. 1994;90:1522-1536.
21. Majors A, Ehrhart LA. Basic fibroblast growth factor in the extracellular matrix suppresses collagen synthesis and type III procollagen mRNA levels in arterial smooth muscle cell cultures. Arterioscler Thromb. 1993;13:680-686.
22. Silver MJ, Sutton JM, Hook S, Lee P, Malycky JL, Phillips LM, Ellis SG, Topol EJ, Nicolini FA. Adjunctive selectin blockade successfully reduces infarct size beyond thrombolysis in the electrolytic canine coronary artery model. Circulation. 1995;92:492-499.
23. Vince DG, Demirkaya O, Cothren RM, Cornhill JF. Quantitative analysis of inflammatory cells in aortic atherosclerosis of young adults. Cardiovasc Pathol. 1996;5:3-10.
24. Takahashi Y, Kitadai Y, Bucana CD, Cleary KR, Ellis LM. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res. 1995;55:3964-3968.
25. Jaeger TM, Weidner N, Chew K, Moore DH, Kerschmann RL, Waldman FM, Carroll PR. Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer. J Urol. 1995;154:69-71.
26. Vermeulen PB, Verhoeven D, Fierens H, Hubens G, Goovaerts G, Van Mark E, De Bruijn EA, Van Oosterom AT, Dirix LY. Microvessel quantifications in primary colorectal carcinoma: an immunohistochemical study. Br J Cancer. 1995;71:340-343.
27. Sasayama S, Nonogi H, Kawai C, Fujita M, Eiho S, Kuwahara M. Automated method for left ventricular volume measurement by cine-ventriculography with minimal doses of contrast medium. Am J Cardiol. 1981;48:746-753.
28. Nichols WW, Nicolini FA, Yang B, Robbins WC, Katopodis J, Chen L, Saldeen TCP, Mehta JL. Attenuation of coronary flow reserve and myocardial function after temporary subtotal coronary occlusion and increased myocardial oxygen demand in dogs. J Am Coll Cardiol. 1994;24:795-803.
29. Schaper W, Gorge G, Winkler B, Schaper J. The collateral circulation of the heart. Prog Cardiovasc Dis. 1988;31:57-77.
30. Winkles JA, Friesel R, Burgess WH, Howk R, Mehlman T, Weinstein R, Maciag T. Human vascular smooth muscle cells both express and respond to heparin-binding growth factor I (endothelial cell growth factor). Proc Natl Acad Sci U S A. 1987;84:7124-7128.
31. Montesano R, Vassalli JD, Baird A, Guillemin R, Orci L. Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci U S A. 1986;83:7297-7301.
32. Pasyk S, Schaper W, Schaper J, Pasyk K, Miskiewicz G, Steinseifer B. DNA synthesis in coronary collaterals after coronary artery occlusion in conscious dog. Am J Physiol. 1982;242:H1031-H1037.
33. Schaper W, De Brabander M, Lewi P. DNA synthesis and mitoses in coronary collateral vessels of the dog. Circ Res. 1971;28:671-679.
34. Bache RJ. Effect of exercise and pharmacologic interventions on coronary collateral blood flow. In: Schaper W, Schaper J, eds. Collateral Circulation: Heart, Brain, Kidney, Limbs. Boston, Mass: Kluwer Academic Publishers; 1993:173-194.
35. Anderson KJ, Dam D, Lee S, Cotman CW. Basic fibroblast growth factor prevents death of lesioned cholinergic neurons in vivo. Nature. 1988;332:360-361.
36. Tilly JL, Billig H, Kowalski KI, Hsueh AJ. Epidermal growth factor and basic fibroblast growth factor suppress the spontaneous onset of apoptosis in cultured rat ovarian granulosa cells and follicles by a tyrosine kinase-dependent mechanism. Mol Endocrinol. 1992;6:1942-1950.
37. Coles HS, Burne JF, Raff MC. Large-scale normal cell death in the developing rat kidney and its reduction by epidermal growth factor. Development. 1993;118:777-784.
38. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature. 1980;284:555-556.
39. Padua RR, Sethi R, Dhalla NS, Kardami E. Basic fibroblast growth factor is cardioprotective in ischemia-reperfusion injury. Mol Cell Biochem. 1995;143:129-135.